TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32946451

Group type: EXPERIMENTAL
Intervention: Olyset LLIN
Number of subjects: 3393

Group type: EXPERIMENTAL
Intervention: PermaNet 2.0 LLIN
Number of subjects: 3393

Group type: EXPERIMENTAL
Intervention: NetProtect LLIN
Number of subjects: 3393

Group type: COMPARATOR
Intervention: All LLIN products
Number of subjects: 3393
Study: 35246403

Group type: EXPERIMENTAL
Intervention: Quantitative flow ratio (QFR)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Fractional flow reserve derived from computed tomography (FFRCT)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Lesion location in right coronary artery (RCA)
Number of subjects: 183
Study: 34261489

Group type: EXPERIMENTAL
Intervention: Lettuce (100 g) with moderately high-fat meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Watercress (100 g) with moderately high-fat meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control meal (cellulose added)
Number of subjects: 16
Study: 35075079

Group type: EXPERIMENTAL
Intervention: Slow rhythm melody music (N=23)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No music (Control group, N=23)
Number of subjects: 46
Study: 34726749

Group type: EXPERIMENTAL
Intervention: Adolescent intervention promoting knowledge and psychosocial outcomes, shared decisional support tool, and logistical strategies.
Number of subjects: 6967

Group type: COMPARATOR
Intervention: Focus group data from intervention schools.
Number of subjects: 6967
Study: 34627673

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both TXA and Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Patients with pneumonia
Number of subjects: 41
Study: 34301422

Group type: EXPERIMENTAL
Intervention: Emergency severity index clinical decision support tool (text banner on triage page)
Number of subjects: 384

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 384
Study: 34820818

Group type: EXPERIMENTAL
Intervention: web-based aftercare
Number of subjects: 142

Group type: COMPARATOR
Intervention: analogue aftercare
Number of subjects: 142
Study: 32830532

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (BLF) supplementation
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 2200
Study: 32087750

Group type: EXPERIMENTAL
Intervention: Geriatric screening care (G8 questionnaire and Timed Up and Go test)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Care as usual (current usual care)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Geriatric screening care
Number of subjects: 320

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 320
Study: 35501401

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention aimed at prevention of GDM and postpartum diabetes
Number of subjects: 516

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 516
Study: 32242394

Group type: EXPERIMENTAL
Intervention: Xinfeng capsule (XFC)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Glucosamine (GS)
Number of subjects: 255
Study: 616871171

Group type: EXPERIMENTAL
Intervention: 20 mg atorvastatin once daily for 6 months
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 35853580

Group type: EXPERIMENTAL
Intervention: 24 week community exercise programme (CEP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard clinical care (control)
Number of subjects: 56
Study: 34593024

Group type: EXPERIMENTAL
Intervention: Collagenase injection
Number of subjects: 710

Group type: COMPARATOR
Intervention: Limited fasciectomy surgery
Number of subjects: 710
Study: 32181677

Group type: EXPERIMENTAL
Intervention: Vitamin D3 60,000 IU between 24 and 48 hours postpartum and at 6, 10, and 14 weeks (total 240,000 IU)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 36279299

Group type: EXPERIMENTAL
Intervention: COACH intervention (integrated care management)
Number of subjects: 2365

Group type: COMPARATOR
Intervention: eCAU (enhanced care-as-usual)
Number of subjects: 2365
Study: 33829984

Group type: COMPARATOR
Intervention: High SFA/low MUFA Control oil (36.6% SFA/28.2% MUFA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional canola oil (6.2% SFA/63.1% MUFA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High oleic acid canola oil (5.8% SFA/74.7% MUFA)
Number of subjects: 0
Study: 36082521

Group type: EXPERIMENTAL
Intervention: TRS‐HFDM without NT‐ProBNP
Number of subjects: 5380

Group type: EXPERIMENTAL
Intervention: TRS‐HFDM with NT‐ProBNP
Number of subjects: 5380
Study: 33512117

Group type: EXPERIMENTAL
Intervention: Bulk-fill composite (Tetric N-Ceram Bulk fill) with universal adhesive (Tetric N-Bond Universal) in O cavity restorations
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bulk-fill composite (Tetric N-Ceram Bulk fill) with universal adhesive (Tetric N-Bond Universal) in MO cavity restorations
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bulk-fill composite (Tetric N-Ceram Bulk fill) with universal adhesive (Tetric N-Bond Universal) in MOD cavity restorations
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intact premolars (control group)
Number of subjects: 60
Study: 33270032

Group type: EXPERIMENTAL
Intervention: Automated texting platform for BP monitoring, 4-month program
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Perfect users (51/201), Adaptive users (66/201), Nonadaptive users (38/201) based on program conformity
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Enthusiast (17/155), Student (35/155), Minimalist (103/155) based on engagement style
Number of subjects: 201
Study: 34258627

Group type: EXPERIMENTAL
Intervention: Low-fat dairy diet (3.3 servings/d)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Full-fat dairy diet (3.3 servings/d)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Limited-dairy diet (≤3 servings/wk of nonfat milk)
Number of subjects: 72
Study: 32193044

Group type: EXPERIMENTAL
Intervention: Etomidate plus fentanyl (group B)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Etomidate plus ketamine (group A)
Number of subjects: 70
Study: 36271753

Group type: EXPERIMENTAL
Intervention: office-based vergence/accommodative therapy
Number of subjects: 205
Study: 33884674

Group type: EXPERIMENTAL
Intervention: High hemoglobin target (>12.5 g/dL)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Low hemoglobin target (<10.5 g/dL)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 1000 IU/day
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control (no vitamin D supplementation)
Number of subjects: 153
Study: 35534590

Group type: EXPERIMENTAL
Intervention: 0.3 M sodium chloride solution
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 0.5 M sodium chloride solution
Number of subjects: 74
Study: 33377565

Group type: EXPERIMENTAL
Intervention: Smartphone application-based dietary self-management program
Number of subjects: 75

Group type: COMPARATOR
Intervention: General program
Number of subjects: 75
Study: 36164077

Group type: EXPERIMENTAL
Intervention: Loncastuximab tesirine (0.15 mg/kg) + rituximab (375 mg/m2) for 2 cycles, then Loncastuximab (0.075 mg/kg) + rituximab (375 mg/m2) for up to 6 additional cycles.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group: Rituximab-gemcitabine-oxaliplatin (R-GemOx) (not yet reported as this is part of the randomized phase).
Number of subjects: 20
Study: 33024322

Group type: EXPERIMENTAL
Intervention: Early vitrectomy (2-4 days post-injury)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Delayed vitrectomy (5-7 days post-injury)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Late vitrectomy (8-14 days post-injury)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Very late vitrectomy (>14 days post-injury)
Number of subjects: 139
Study: 33131170

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser combined with L-GFs
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fractional CO2 laser combined with PRP
Number of subjects: 45
Study: 36078667

Group type: EXPERIMENTAL
Intervention: Short-term psychoanalytic psychotherapy (STPP) with transference work
Number of subjects: 69

Group type: COMPARATOR
Intervention: Short-term psychoanalytic psychotherapy (STPP) without transference work
Number of subjects: 69
Study: 33038035

Group type: EXPERIMENTAL
Intervention: LSTM network for predicting fluid responsiveness
Number of subjects: 175

Group type: COMPARATOR
Intervention: Point-of-care US experts using video review and manual measurement
Number of subjects: 175
Study: 32681091

Group type: EXPERIMENTAL
Intervention: vorinostat, tamoxifen and pembrolizumab
Number of subjects: 34
Study: 35192839

Group type: EXPERIMENTAL
Intervention: PROTECT III
Number of subjects: 504
Study: 35769842

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg daily for 10 days
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (colistin only)
Number of subjects: 82
Study: 32949145

Group type: EXPERIMENTAL
Intervention: Health System-Based Dementia Care (HSDC)
Number of subjects: 2150

Group type: EXPERIMENTAL
Intervention: Community-Based Dementia Care (CBDC)
Number of subjects: 2150

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 2150
Study: 35986297

Group type: EXPERIMENTAL
Intervention: Acupuncture based on syndrome differentiation with donepezil (5 mg/day) for 12 weeks
Number of subjects: 184

Group type: COMPARATOR
Intervention: Donepezil (5 mg/day)
Number of subjects: 184
Study: 32162970

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 μg
Number of subjects: 10355

Group type: COMPARATOR
Intervention: Fluticasone furoate/umeclidinium/vilanterol (FF/VI) 100/25 μg
Number of subjects: 10355

Group type: COMPARATOR
Intervention: Umeclidinium/vilanterol (UMEC/VI) 62.5/25 μg
Number of subjects: 10355
Study: 34774885

Group type: EXPERIMENTAL
Intervention: FDY-5301 (2.0 mg/kg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: FDY-5301
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: FDY-5301 (0.5 mg/kg and 1.0 mg/kg)
Number of subjects: 120
Study: 34776199

Group type: EXPERIMENTAL
Intervention: Mat Pilates (PG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 40
Study: 35923518

Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control (cord clamped and cut without milking)
Number of subjects: 170
Study: 35537896

Group type: EXPERIMENTAL
Intervention: Maxilla-first approach (group I)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mandible-first approach (group II)
Number of subjects: 24
Study: 32057733

Group type: EXPERIMENTAL
Intervention: Hyrax T‐RME
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dresden B‐RME
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 50
Study: 34939609

Group type: EXPERIMENTAL
Intervention: Lower limb high-intensity interval training (HIIT) for 23 minutes
Number of subjects: 2

Group type: COMPARATOR
Intervention: Seated rest for 23 minutes
Number of subjects: 2
Study: 32389434

Group type: EXPERIMENTAL
Intervention: Personalized decision aid intervention
Number of subjects: 184

Group type: COMPARATOR
Intervention: CDC brochure about falls (Control)
Number of subjects: 184
Study: 35049203

Group type: EXPERIMENTAL
Intervention: SUBAR-assisted gait training (n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional physiotherapy (control group, n=15)
Number of subjects: 30
Study: 35243362

Group type: EXPERIMENTAL
Intervention: STAR care pathway plus usual care (n=242)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Usual care alone (n=121)
Number of subjects: 363
Study: 34621380

Group type: EXPERIMENTAL
Intervention: Asthma patients
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Asthma patients with CC genotype
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Asthma patients with AA genotype
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: TLR-4 rs4986791 polymorphism
Number of subjects: 150
Study: 33526271

Group type: EXPERIMENTAL
Intervention: SURE RAB™ (inactivated cell culture derived rabies vaccine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: VERORAB (approved rabies vaccine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined Group I + II (SURE RAB™ and VERORAB)
Number of subjects: 0
Study: 34989778

Group type: EXPERIMENTAL
Intervention: 5-day regimen of postoperative prophylactic intravenous cephalosporin (cefazolin or cefuroxime)
Number of subjects: 604

Group type: COMPARATOR
Intervention: 1-day regimen of postoperative prophylactic intravenous cephalosporin (cefazolin or cefuroxime)
Number of subjects: 604
Study: 34086034

Group type: EXPERIMENTAL
Intervention: Rapid respiratory pathogen test results given to clinicians
Number of subjects: 931

Group type: COMPARATOR
Intervention: Routine clinical care (control group)
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Rapid respiratory pathogen test results known to clinicians (modified intention-to-treat analysis)
Number of subjects: 931
Study: 33073449

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g day−1 for 5 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Creatine-Isotime (time matched to Baseline after creatine supplementation)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo-Isotime (time matched to Baseline after placebo supplementation)
Number of subjects: 16
Study: 36470312

Group type: EXPERIMENTAL
Intervention: Endovenous Laser Ablation (EVLA)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Ultrasound‐Guided‐Foam Sclerotherapy (UGFS)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Both groups (EVLA and UGFS)
Number of subjects: 161
Study: 34411729

Group type: EXPERIMENTAL
Intervention: vNOTES
Number of subjects: 96

Group type: COMPARATOR
Intervention: CL
Number of subjects: 96
Study: 32748181

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (LCS)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional cataract surgery
Number of subjects: 34
Study: 33765935

Group type: EXPERIMENTAL
Intervention: Comprehensive orthogeriatric care (CGC)
Number of subjects: 726
Study: 33348935

Group type: EXPERIMENTAL
Intervention: PRP intradermal injection
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: FCL followed by topical PRP
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Microneedling followed by topical PRP
Number of subjects: 60
Study: 35781816

Group type: EXPERIMENTAL
Intervention: 5 mg/kg VE
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 10 mg/kg VE
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 20 mg/kg VE
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 40 mg/kg VE
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 80 mg/kg VE
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (basal diet)
Number of subjects: 240
Study: 33980208

Group type: EXPERIMENTAL
Intervention: Simple Decision Aid (DA)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Complex Decision Aid (DA)
Number of subjects: 285
Study: 32298381

Group type: EXPERIMENTAL
Intervention: Siriraj Surgical ICU Nutrition Protocol
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control group (nutrition at discretion of attending physicians)
Number of subjects: 170
Study: 33654316

Group type: EXPERIMENTAL
Intervention: PVP-I 0.6% eye drops four times/daily for 20 days
Number of subjects: 59

Group type: COMPARATOR
Intervention: Hyaluronate-based tear substitutes four times/daily for 20 days
Number of subjects: 59
Study: 32816021

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Fibrin Matrix (PRFM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PRFM
Number of subjects: 30
Study: 36128685

Group type: EXPERIMENTAL
Intervention: Enhanced follow-up by stoma therapists with regular consultations after discharge
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard follow-up
Number of subjects: 0
Study: 35545816

Group type: EXPERIMENTAL
Intervention: ZFR00V multifocal intraocular lens (model ZFR00V)
Number of subjects: 150

Group type: COMPARATOR
Intervention: TFNT00 trifocal intraocular lens (model TFNT00)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Both IOLs
Number of subjects: 150
Study: 34156881

Group type: EXPERIMENTAL
Intervention: PET-driven group (doxorubicin, bleomycin, vinblastine, and dacarbazine regimen after two cycles of BEACOPPescalated)
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: PET-driven group
Number of subjects: 569
Study: 32246682

Group type: EXPERIMENTAL
Intervention: Oral diclofenac (50 mg twice daily)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Transdermal diclofenac patch (100 mg once daily)
Number of subjects: 32
Study: 35799456

Group type: EXPERIMENTAL
Intervention: Advanced hydropolymer wound dressing with smartphone technology
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 200
Study: 34584010

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Noninvasive Ventilation (NIV)
Number of subjects: 109
Study: 33038280

Group type: EXPERIMENTAL
Intervention: Adiponectin
Number of subjects: 114530

Group type: EXPERIMENTAL
Intervention: Leptin
Number of subjects: 114530

Group type: EXPERIMENTAL
Intervention: Soluble leptin receptor (sOB-R)
Number of subjects: 114530

Group type: EXPERIMENTAL
Intervention: Plasminogen activator inhibitor-1 (PAI-1)
Number of subjects: 114530
Study: 32540842

Group type: EXPERIMENTAL
Intervention: One Drop with activity tracker
Number of subjects: 99

Group type: COMPARATOR
Intervention: One Drop only
Number of subjects: 99
Study: 33825577

Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: Endovascular revascularization
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: Vascular surgeons
Number of subjects: 936

Group type: COMPARATOR
Intervention: Nonsurgical interventionalists
Number of subjects: 936
Study: 33095849

Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation (n=300)
Number of subjects: 596

Group type: COMPARATOR
Intervention: Systemic heparin anticoagulation (n=296)
Number of subjects: 596
Study: 35849138

Group type: EXPERIMENTAL
Intervention: Navigation to resources (NAV) facilitated by a Patient Navigator
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: NAV + evidence-based nine-session diabetes self-management support (DSMS) program facilitated by a community health worker (CHW)
Number of subjects: 110

Group type: COMPARATOR
Intervention: NAV
Number of subjects: 110

Group type: COMPARATOR
Intervention: NAV + DSMS
Number of subjects: 110
Study: 35142643

Group type: EXPERIMENTAL
Intervention: DRL_TZ (6 mg/kg, single intravenous infusion)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Herceptin® (6 mg/kg, single intravenous infusion)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: DRL_TZ
Number of subjects: 32

Group type: COMPARATOR
Intervention: Herceptin®
Number of subjects: 32
Study: 35195798

Group type: EXPERIMENTAL
Intervention: BIO‐A mesh supported colostomy (Mesh Group)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional colostomy (Control Group)
Number of subjects: 110
Study: 34444121

Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment (NSPT) with community health worker (CHW) strategy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Nonsurgical periodontal treatment (NSPT)
Number of subjects: 68
Study: 32276676

Group type: EXPERIMENTAL
Intervention: Resin infiltration (test)
Number of subjects: 28

Group type: COMPARATOR
Intervention: No infiltration (control)
Number of subjects: 28
Study: 35038479

Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 37

Group type: COMPARATOR
Intervention: Neurostimulation alone without cognitive restructuring
Number of subjects: 37
Study: 34708471

Group type: EXPERIMENTAL
Intervention: Probiotics containing Lactobacillus acidophilus and Lactobacillus rhamnosus
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32272253

Group type: EXPERIMENTAL
Intervention: Fluoroscopic guided spinal biopsy
Number of subjects: 60

Group type: COMPARATOR
Intervention: CT guided spinal biopsy
Number of subjects: 60
Study: 35901118

Group type: EXPERIMENTAL
Intervention: Prosocial behavior
Number of subjects: 1234

Group type: COMPARATOR
Intervention: Self-focused behavior
Number of subjects: 1234

Group type: COMPARATOR
Intervention: Neutral behavior
Number of subjects: 1234
Study: 33383580

Group type: EXPERIMENTAL
Intervention: Multidose metronidazole for male partners (2×/day for 7 days)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo for male partners
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Adherence to multidose metronidazole by male partners
Number of subjects: 214
Study: 36151343

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP) with oral antibiotics (OA) using Alfa Normix®
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mechanical bowel preparation (MBP) alone
Number of subjects: 0
Study: 33137675

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted inferior turbinoplasty (MAIT)
Number of subjects: 77
Study: 34231290

Group type: EXPERIMENTAL
Intervention: Standardized outpatient cardiac rehabilitation combined with treadmill power walking (intervention group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standardized outpatient cardiac rehabilitation alone (control group)
Number of subjects: 24
Study: 33017172

Group type: EXPERIMENTAL
Intervention: Mindfulness-based resilience training (MBRT)
Number of subjects: 28
Study: 34942066

Group type: EXPERIMENTAL
Intervention: BNT162b2
Number of subjects: 219842

Group type: COMPARATOR
Intervention: mRNA-1273
Number of subjects: 219842
Study: 33975053

Group type: EXPERIMENTAL
Intervention: Learning Together intervention, a school-based intervention including restorative practice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Learning Together intervention
Number of subjects: 0
Study: 33583304

Group type: EXPERIMENTAL
Intervention: Smart Cuff Manager (SCM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual Measurement Approach (MMA)
Number of subjects: 60